Get the Stockscreener App
1.73
6.49%
-0.12
After Hours:
1.75
0.02
+1.16%
Gelteq Ltd stock is traded at $1.73, with a volume of 51,081.
It is down -6.49% in the last 24 hours and up +0.00% over the past month.
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
See More
Previous Close:
$1.85
Open:
$1.85
24h Volume:
51,081
Relative Volume:
0.04
Market Cap:
$18.55M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-7.49%
1M Performance:
+0.00%
6M Performance:
-23.11%
1Y Performance:
+0.00%
1-Day Range:
$1.73
$1.8782
1-Week Range:
$1.73
$1.94
52-Week Range:
$0.7701
$5.50
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
1.73 | 18.55M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Gelteq Ltd Stock (GELS) Latest News
What is Gelteq Limited company’s growth strategyLow Risk Growth Plan With Low Risk - jammulinksnews.com
Is Gelteq Limited Starting a New UptrendMomentum Based Equity Trading Plans Reviewed - metal.it
How to forecast Gelteq Limited trends using time seriesIntraday Movement Recap and Chart Summary - Newser
How strong is Gelteq Limited company’s balance sheetCapitalize on emerging market trends - jammulinksnews.com
How does Gelteq Limited compare to its industry peersFree Expert Stock Watchlist - jammulinksnews.com
What analysts say about Gelteq Limited stockFree Stock Index Interpretation - jammulinksnews.com
Is Gelteq Limited a good long term investmentConsistent triple returns - Autocar Professional
Gelteq Limited Stock Analysis and ForecastFree Predictions - jammulinksnews.com
What drives Gelteq Limited stock priceHigh-profit capital plays - jammulinksnews.com
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - The Manila Times
Gelteq partners with IDT Australia for dedicated gel manufacturing facility - Investing.com Australia
Gelteq Limited Partners with IDT Australia to Establish Local Manufacturing Facility for Gel-Based Products - Nasdaq
Gelteq Partners With IDT Australia for Global Pharmaceutical Manufacturing Facility | GELS Stock News - Stock Titan
IDT Australia Signs Manufacturing Facility Deal for Gelteq's Products - 富途牛牛
How Gelteq Limited stock performs during market volatilityHigh Accuracy Alerts - Newser
What makes Gelteq Limited stock price move sharplyLow Risk Trade Timing Signals - Newser
Why Gelteq Limited stock attracts strong analyst attentionFree Investment Group - Newser
Gelteq Stock Soars On Deal With Healthy Extracts For Product Distribution In North America: Retail Chatter Explodes - Investing.com India
Gelteq Expands US Footprint With Healthy Extracts Logistics Deal, Stock Surges - Benzinga
Gelteq partners with Healthy Extracts for North American logistics - Investing.com Australia
Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner - The Manila Times
Gelteq partners with Healthy Extracts for North American logistics By Investing.com - Investing.com UK
Gelteq Accelerates US Growth: Strategic Partnership Unlocks Nationwide Distribution Network - Stock Titan
Gelteq Limited Soars on U.S. Expansion News: What’s Driving the Surge? - RagingBull
Why Toll Brothers Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Gelteq Ltd (GELS) Stock: A Year of Market Movement, Down and Up - investchronicle.com
Gelteq Ltd (GELS) Volatility Hits 28.96% – Here Is What You Should Do - Stocksregister
Promising Penny Stocks To Watch Now – April 22nd - Defense World
Top Biotech Stocks To Watch Today – April 22nd - Defense World
Enphase Energy Posts Downbeat Results, Joins Watsco And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
SmallCaps Gaining Momentum: TIVC, GELS, SLI, OBIO - openPR.com
SmallCaps Gaining Momentum: TIVC, GELS, SLI, OBIO in Healthcare, Biotech, Energy, Military Defense, Etc. – More Stocks Inside | FinancialContent - FinancialContent
Gelteq Ltd (GELS) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Dow Jumps Over 400 Points; Verizon Earnings Top Views - Benzinga
Sweetgreen Inc Inc. (SG) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
GELS Stock Price and Chart — NASDAQ:GELS - TradingView
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Gelteq LimitedOrdinary Shares (NQ: GELS - FinancialContent
XD Inc. (OTCMKTS:XDNCF) Short Interest Update - Defense World
Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga
CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga
Sometimes it’s not the drug, but how it’s delivered - Townsville Bulletin
Aspire Biopharma Hldgs Stock Price, Quotes and Forecasts | NASDAQ:ASBP - Benzinga
Gelteq introduces SportsGel with China deal in H1 2025 - Investing.com India
Gelteq Ltd Stock (GELS) Financials Data
There is no financial data for Gelteq Ltd (GELS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):